FDA Preclearance Of DTC Ads Included In Sen. Kennedy Draft Bill
This article was originally published in The Pink Sheet Daily
Executive Summary
Legislation would allow FDA to pre-approve ads from repeat offenders. TV ads would need to include full MedGuide information. Draft language also calls for ad disclaimers on new drugs for two years.
You may also be interested in...
Misleading Drug Ads Should Be Subject To Financial Penalties, AARP Says
Congress should implement financial penalties for misleading drug ads, AARP Executive Director for State & National Initiatives Christopher Hansen said
Misleading Drug Ads Should Be Subject To Financial Penalties, AARP Says
Congress should implement financial penalties for misleading drug ads, AARP Executive Director for State & National Initiatives Christopher Hansen said
Alternatives To Brief Summary Outlined In Draft Guidance
One of FDA's three draft guidances on DTC advertising requests that consumer-friendly language be used. Commissioner McClellan calls proposed brief summary alternatives a "win-win" and suggests manufacturers will be able to reduce their advertising costs as a result.